Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Onyx Pharma delays NDA submission for carfilzomib

Oct. 11, 2010

MD Anderson Cancer Center investigates antitumor potential of CG-100649

Oct. 11, 2010

French scientists present new inhibitors of CDK1, CDK5 activator 1 and/or GSK-3

Oct. 11, 2010

Debio-0719 suppresses metastasis in mouse models of breast cancer

Oct. 11, 2010

PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial

Oct. 11, 2010

ChemGenex completes pre-NDA meeting with FDA for Omapro

Oct. 8, 2010

FDA agrees to SPA for phase III Estybon trial in myelodysplastic syndromes

Oct. 8, 2010

NCI and Lixte Biotechnology collaborate on anticancer agent LB-100

Oct. 8, 2010

Stemsynergy Therapeutics claims new Wnt signaling inhibitors

Oct. 8, 2010

U.S. researchers claim new DNA topoisomerase 1 inhibitors

Oct. 7, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...